Industry Experts Join AZ Leaders to Discuss Value in Healthcare

Posted by

Meredith Hemler

How is value defined by healthcare’s many stakeholders? How can the priorities of these stakeholders be pursued to get the best result for patients? How can the U.S. healthcare system improve patient health, while lowering the cost of care?

Paul Spittle, Vice President of Growth and Marketing, AstraZeneca

These questions and others were explored on Monday, July 14, as AstraZeneca executives – including Paul Spittle, Vice President of Growth and Marketing; Diane Sullivan, Vice President of Market Access & Patient Strategies; and Rich Buckley, Vice President of North America Corporate Affairs – hosted a group of industry experts in Washington, D.C. for a dinner discussion about the concept of value in today’s evolving healthcare environment.

Participants represented a broad range of stakeholders, from insurance and hospital executives, to nonprofit groups, policy experts and media. Julie Rovner, Robin Toner Distinguished Fellow and Senior Correspondent for Kaiser Health News, served as moderator for the discussion.

Participants discussed how the definitions and perceptions of value are wide-ranging and constantly evolving (over time and through changing circumstances), making it difficult to identify effective and sustainable solutions to improve healthcare.  Despite these challenges, the group explored a number of actions that can be taken to help strengthen and preserve the quality of healthcare for patients while controlling costs — from better harnessing the power of available data and technology, to offering wellness and preventable care programs, to engaging patients in the health value discussion in a truly meaningful way.

The dinner was part of a series of events coordinated by National Journal LIVE, a premier events business that convenes top leaders in the Washington, D.C. area to discuss possible solutions to the country’s biggest challenges.

Rich Buckley, Vice President of North America Corporate Affairs and Diane Sullivan, Vice President of Market Access & Patient Strategies, AstraZeneca